2021-01-23 SAPA-NE 22nd Annual Conference: A New Era in Biotech and Life Science

Updated: Jan 7

To subscribe SAPNE-NE Events: https://www.sapa-neweb.org/subscribe


22nd SAPA-NE Annual Conference


Event Program Details

SAPA-NE 22nd Annual Conference: A New Era in Biotech and Life Science

Saturday, January 23rd, 2021

One Day Free Zoom Webinar (9AM-6PM)

Register Now

(number of seats are limited)

The event features presentations and panel discussions presented by distinguished speakers/panelists in academic or industry.


Topics include:

  • Breakthrough science and technologies for novel therapies

  • Disruptive innovations for drug discovery and development

  • Development in diagnostic tools and precision medicines

  • Pharmaceutical and biotech investment and global partnership trends


Keynote speakers at the 22nd SAPA-NE Annual Conference

  • Eric Fischer, Ph.D. Independent Investigator at DFCI Associate Professor at HMS, and Co-Director of the DFCI Center for Protein Degradation [Presentation: Principles of Small Molecule Mediated Ubiquitin Ligase Targeting]

  • Robert Flaumenhaft, M.D., Ph.D. Professor, Chief, Division of Hemostasis and Thrombosis, BIDMC, Harvard Medical School

  • Jamie Stokes, Ph.D. Principal Research Scientist at Concept Life Sciences [Presentation: Synthesis and Characterisation of Antibody Drug Conjugates]

  • Zonghai Li, M.D., Ph.D. Chairman, Chief Executive Officer, Chief Scientific Officer and Founder of CARsgen Therapeutics

  • Yan Chen, Ph.D. Founder, President and CEO of Elpis Biopharmaceuticals [Presentation: mRNA Display Technologies Enable Rapid Antibody Discovery and Protein Engineering to Harness Immuno-Oncology Therapeutics]

  • Dian Su, Ph.D. Sr. Scientist, Drug Metabolism and Pharmacokinetics at Genentech [Presentation: Pave the Road to Drug the Undruggable: Driving ADC Discovery from the DMPK Perspective]

  • Liang Schweizer, Ph.D. Co-founder, President and CEO of HiFiBiO Therapeutics [Presentation: Pioneering “Drug Intelligent Science” – a Novel Single Cell Approach for Drug Discovery and Development]

  • Jamie Stokes, Ph.D. Principal Research Scientist at Concept Life Sciences [Presentation: Synthesis and Characterisation of Antibody Drug Conjugates]

  • Aimin Hui, M.D, Ph.D. President of Global R&D, CMO, and Chair of the Scientific Committee of Fosun Pharma [Presentation: Journey of COVID-19 Vaccine- from Ten Years to One Year]

  • Julia Ding, Ph.D. Director, Global Process Analytical Development at Bristol Myers Squibb [Presentation: Paving the Way for Real time Product Quality Attribute and Bioprocess Monitoring in Biologics Development]

Register Now

Lunch Career Discussion Panelists

  • Brad Warsen, Executive Director of Quality for the Devens Cell Therapy Facility at BMS

  • Sanchayita Ghose, Ph.D., Executive Director, Head of Global Downstream Bioprocess Development at BMS

  • Ji Li, Ph.D., Principle Scientist, Mechanism of Cancer Resistance TRC at BMS

  • Chun Shao, Ph.D., Principle Scientist, Process Development Analytics at BMS


Register Now

Selected speakers from past events:

  • Dr. Dudley Herschbach (1986 Nobel Laureate, Prof., Harvard Univ.)

  • Dr. Craig Mello (2006 Nobel Laureate, Prof., U Mass)

  • Dr. Jack Szostak (2009 Nobel Laureate, Prof., MGH, Harvard Medical School)

  • Dr. Bruce Beutler (2011 Nobel Laureate, Prof., UT Southwestern Medical Center)

  • Dr. Ken Chien (Prof. Harvard)

  • Dr. George Church (Harvard)

  • Dr. Christine A. Poon (Vice Chairman, Johnson & Johnson)

  • Dr. JC Gutierrez-Ramos (SVP & CSO, Pfizer)

  • Dr. John LaMattina (SVP, Pfizer)

  • Dr. Robert R. Ruffolo (R&D President, Wyeth)

  • Drs. Mark Levick and Karin Briner (VP, Novartis)

  • Dr. Kathleen Metters (SVP, Merck)

  • Dr. Yong-Jun Liu (Head of Research, Sanofi)

  • Dr. Joanne Beck (VP, Shire)

  • Dr. Deborah Dunsire (CEO, Millennium)

  • Dr. Gunther Winkler (SVP, Biogen-Idec)

  • Dr. Andrew Plump (CMSO, Takeda)

  • Dr. Richard Murray (CEO, Jounce Therapeutics)

  • Dr. Edward Hu (Co-CEO, WUXI AppTec)

  • Dr. Gregory Verdine (CEO, Fog Pharmaceuticals & LifeMine Therapeutics)

  • Dr. Sridaran Natesan, (VP, Sanofi)

  • Dr. Shaun R. Coughlin, (VP, Novartis)

Call for Sponsors for 22nd SAPA-NE Annual Conference


SAPA-NE 22nd Annual Conference: A New Era in Biotech and Life Science

January 23rd, 2021

Zoom Webinar

Please click the link to register (number of seats are limited):




Recent SAPA-NE Annual Conference:

To subscribe SAPNE-NE Events: https://www.sapa-neweb.org/subscribe

141 views0 comments
  • Twitter Social Icon
  • LinkedIn Social Icon

© Copyright 2004 - 2020 - SAPA NE

Sino-American Pharmaceutical Professionals Association, New England Chapter (SAPA-NE)

Please send your comments and suggestions to info@sapa-neweb.org.

Number of times visited since May, 20th, 2020